HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deoxycholic Acid Upregulates Serum Golgi Protein 73 through Activating NF-κB Pathway and Destroying Golgi Structure in Liver Disease.

Abstract
Golgi protein 73 (GP73) is upregulated in a variety of liver diseases, yet the detailed mechanism is poorly characterized. We analyzed GP73 in a retrospective cohort including 4211 patients with chronic liver disease (CLD) or hepatocellular carcinoma (HCC). The effect of deoxycholic acid (DCA) and nuclear factor-kappa B (NF-κB) on expression and release of GP73 in Huh-7 and SMMC7721 cells were studied. A mouse study was used to confirm our findings in vivo. A positive correlation was found between serum GP73 and total bile acid (TBA) in cirrhotic patients (r = 0.540, p < 0.001), higher than that in non-cirrhotic CLD (r = 0.318, p < 0.001) and HCC (r = 0.353, p < 0.001) patients. In Huh-7 and SMMC7721 cells, DCA upregulated the expression and release of GP73 in a dose- and time-dependent manner. After overexpressing NF-κB p65, the promoter activity, GP73 messenger RNA (mRNA) level, and supernatant GP73 level were increased. The promotion effect of DCA on GP73 release was attenuated after inhibiting the NF-κB pathway. Mutating the binding sites of NF-κB in the sequence of the GP73 promoter led to a declined promoting effect of DCA on GP73. The upregulation role of DCA in GP73 expression through the NF-κB pathway was confirmed in vivo. In addition, exposure to DCA caused disassembly of Golgi apparatus. In summary, DCA upregulates the expression and release of GP73 via activating the NF-κB pathway and destroying the Golgi structure.
AuthorsDanli Yang, Mingjie Yao, Ying Yan, Yanna Liu, Xiajie Wen, Xiangmei Chen, Fengmin Lu
JournalBiomolecules (Biomolecules) Vol. 11 Issue 2 (02 02 2021) ISSN: 2218-273X [Electronic] Switzerland
PMID33540642 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bile Acids and Salts
  • GOLM1 protein, human
  • GP73 protein, mouse
  • Membrane Proteins
  • NF-kappa B p50 Subunit
  • NFKB1 protein, human
  • Phosphoproteins
  • Deoxycholic Acid
  • Nfkb1 protein, mouse
Topics
  • Adult
  • Animals
  • Bile Acids and Salts (metabolism)
  • Carcinoma, Hepatocellular (drug therapy, metabolism)
  • Cell Line, Tumor
  • Chronic Disease
  • Deoxycholic Acid (metabolism, pharmacology)
  • Female
  • Fibrosis
  • Gene Expression Profiling
  • Humans
  • Liver Cirrhosis (drug therapy, metabolism)
  • Liver Diseases (drug therapy, metabolism)
  • Liver Neoplasms (drug therapy, metabolism)
  • Male
  • Membrane Proteins (biosynthesis)
  • Mice
  • Mice, Inbred C57BL
  • Microscopy, Fluorescence
  • Middle Aged
  • NF-kappa B p50 Subunit (biosynthesis)
  • Phosphoproteins (biosynthesis)
  • Retrospective Studies
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: